title: Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levels.
abstract: In a previous study, we observed an impairment of the theophylline-induced suppressive system in recent onset IDDM patients, and demonstrated also a correlation with metabolic derangement. The aim of this study was to better investigate the relationship between theophylline sensitivity (ThS) and blood glucose/plasma insulin levels in recent onset IDDM patients subjected to preprogrammed variations by an insulin/glucose clamp with artificial pancreas. Eight patients were studied within 8 weeks from the onset of IDDM. ThS was evaluated as the ability of theophylline to inhibit blastogenic response of peripheral blood lymphocytes (PBL) to Concanavalin A (ConA), after 120 min preincubation of the cells. All patients were connected to an artificial pancreas. Through i.v. continuous insulin infusion (0.02 U/kg/h) and/or i.v. continuous glucose and saline infusion, the following experimental conditions, lasting at least 1h, were obtained: T1: relative euglycemia and normal insulinemia; T2: relative euglycemia and hyperinsulinemia; T3: hyperglycemia and normal insulinemia; T4: hyperglycemia and hyperinsulinemia. ThS was maintained in 6/8 patients at T1 and in 8/8 patients at T4. ThS was lost in 4/8 patients at T2 and T3. These data suggest that the loss of ThS induced by hyperglycemia can be corrected by hyperinsulinemia, and that it is maintained when euglycemia is accompanied by hypoinsulinemia. It is lost when these two parameters lose their interrelationship.
authors.affiliation: Istituto Scientifico San Raffaele, Università degli Studi di Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Secchi
authors.forename: F
authors.initials: F
authors.lastname: Crosti
authors.forename: L
authors.initials: L
authors.lastname: Bonisolli
authors.forename: D
authors.initials: D
authors.lastname: Pavoni
authors.forename: F
authors.initials: F
authors.lastname: Capra
authors.forename: P
authors.initials: P
authors.lastname: Navone
authors.forename: A E
authors.initials: AE
authors.lastname: Pontiroli
authors.forename: M
authors.initials: M
authors.lastname: Bellone
authors.forename: C
authors.initials: C
authors.lastname: Rugarli
authors.forename: G
authors.initials: G
authors.lastname: Pozza
mesh_terms: D000204:Activity Cycles; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D003208:Concanavalin A; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D013806:Theophylline / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D003208:Concanavalin A; D013806:Theophylline